A single parasite gene determines strain-specific protective immunity against malaria: The role of the merozoite surface protein I

International Journal for Parasitology

Volumn 40, Issue 8, 2010, Pages 951-961

  Cheesman, Sandra ^a   O'Mahony, Elaine ^a   Pattaradilokrat, Sittiporn ^b   Degnan, Kathryn ^a   Knott, Sara ^a   Carter, Richard ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEROZOITE SURFACE PROTEIN 1;

CHROMOSOME; GENOME; IMMUNE RESPONSE; IMMUNITY; MALARIA; PARASITE; PROTEIN;

ALLELE; ARTICLE; CHROMOSOME; CHROMOSOME 8; CONTROLLED STUDY; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; IMMUNE RESPONSE; IMMUNITY; MALARIA; NONHUMAN; ORGANISMS BY LIFE CYCLE STAGE; PROGENY; PROMOTER REGION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN SPECIFIC PROTECTIVE IMMUNITY;

ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; FEMALE; MALARIA; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED CBA; PLASMODIUM CHABAUDI; POLYMORPHISM, SINGLE NUCLEOTIDE; SELECTION, GENETIC;

MUS; PLASMODIUM CHABAUDI CHABAUDI;

EID: 77952973648     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.02.003     Document Type: Article

References (41)

1. Alonso P.L. Malaria, deploying a candidate vaccine (RTS, S/AS02A) for an old scourge of humankind. Int. Microbiol. 2006, 9:83-93.
2. Audran R., Cachat M., Lurati F., Soe S., Leroy O., Corradin G., Druilhe P., Spertini F. Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen. Infect. Immun. 2005, 73:8017-8026.
3. Bahl A., Brunk B., Crabtree J., Fraunholz M.J., Gajria B., Grant G.R., Ginsburg H., Gupta D., Kissinger J.C., Labo P., Li L., Mailman M.D., Milgram A.J., Pearson D.S., Roos D.S., Schug J., Stoeckert C.J., Whetzel P. PlasmoDB, the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res. 2003, 31:212-215.
4. Branch O.H., Udhayakumar V., Hightower A.W., Oloo A.J., Hawley W.A., Nahlen B.L., Bloland P.B., Kaslow D.C., Lal A.A. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants, associations with febrile illness, parasitemia, and anemia. Am. J. Trop. Med. Hyg. 1998, 58:211-219.
5. Cardigan F.C., Chaicumpa V. Plasmodium falciparum in the white handed gibbon, protection afforded by previous infection with homologous and heterologous strains obtained in Thailand. Mil. Med. 1969, 134:1135-1139.
6. Carlton J.M., Howard J., Jensen J.B., Walliker D. A rapid technique for the detection of DNA polymorphisms in Plasmodium. Exp. Parasitol. 1995, 80:163-166.
7. Carter R., Walliker D. New observations on the malaria parasites of rodents in the Central African Republic-Plasmodium vinckei petteri subsp.nov. and Plasmodium chabaudi Landau, 1965. Ann. Trop. Med. Parasitol. 1975, 69:187-196.
8. Carter R. Studies on enzyme variation in the murine malaria parasites Plasmodium bergei, P. yoelii, P. vinkei and P. chabaudi by starch gel electrophoresis. Parasitology 1978, 76:241-267.
9. Carter R., Hunt P., Cheesman S. Linkage group selection - a fast approach to the genetic analysis of malaria parasites. Int. J. Parasitol. 2007, 37:285-293.
10. Cavanagh D.R., Dodoo D., Hviid L., Kurtzhals J.A.L., Theander T.G., Akanmori B.D., Polley S., Conway D.J., Koram K., McBride J.S. Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect. Immun. 2004, 72:6492-6502.
11. Cheesman S., Raza A., Carter R. Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice. Infect. Immun. 2006, 74:2996-3001.
12. Cheesman S., Creasey A., Degnan K., Kooij T., Afonso A., Cravo P., Carter R., Hunt P. Validation of Pyrosequencing™ for accurate and high throughput estimation of allele frequencies in malaria parasites. Mol. Biochem. Parasitol. 2007, 152:213-219.
13. Cheesman S., Tanabe K., Sawai H., O'Mahony E., Carter R. Strain-specific immunity may drive adaptive polymorphism in the merozoite surface protein 1 of the rodent malaria parasite Plasmodium chabaudi. Infect. Genet. Evol. 2009, 9:248-255.
14. Conway D.J., Cavanagh D.R., Tanabe K., Roper C., Mikes Z.S., Sakihama N., Bojang K.A., Oduola A.M.J., Kremsner P.G., Arnot D.E., Greenwood B.M., McBride J.S. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 2000, 6:689-692.
15. Egan A.F., Morris J., Baruish G., Allen S., Greenwood B.M., Kaslow D.C., Holder A.A., Riley E.M. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 1996, 173:765-769.
16. Eisen D.P., Billman-Jacobe H., Marshall V.F., Fryauff D., Coppel R.L. Temporal variation of the merozoite surface protein-2 gene of Plasmodium falciparum. Infect. Immun. 1998, 66:239-246.
17. Eisen D.P., Saul A., Fryauff D.J., Reeder J.C., Coppel R.L. Alterations in Plasmodium falciparum genotypes during sequential infections suggest the presence of strain specific immunity. Am. J. Trop. Med. Hyg. 2002, 67:8-16.
18. Gardner M., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
19. Genton A., Betuela I., Felger I., Al-Yaman F., Anders R.F., Saul A., Rare L., Baisor M., Lorry K., Brown G.V., Pye D., Irving D.O., Smith T.A., Beck H.P., Alpers M.P. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 2002, 185:820-827.
20. Goel V.K., Li X., Chen H., Liu S., Chishti A.H., Oh S.S. Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. Proc. Natl. Acad. Sci. USA 2003, 100:5164-5169.
21. Grech K., Martinelli A., Pathirana S., Walliker D., Hunt P., Carter R. Numerous, robust genetic markers for Plasmodium chabaudi by the method of amplified fragment length polymorphism. Mol. Biochem. Parasitol. 2002, 123:95-104.
22. Holder A.A., Riley E.M. Human immune responses to MSP-1. Parasitol. Today 1996, 12:173-174.
23. Hu J., Chen Z., Gu J., Wan M., Shen Q., Kieny M.P., He J., Li Z., Zhang Q., Reed Z.H., Zhu Y., Li W., Cao Y., Qu L., Cao Z., Wang Q., Liu H., Pan X., Huang X., Zhang D., Xue X., Pan W. Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults. PLoS ONE 2008, 3:e1952.
24. Janse C.J., Carlton J.M., Walliker D., Waters A.P. Conserved location of genes on polymorphic chromosomes of four species of malaria parasites. Mol. Biochem. Parasitol. 1994, 68:285-296.
25. Jarra W., Brown K.N. Protective immunity to malaria, studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter- and intra-species specificity of immunity induced by infection. Parasite Immunol. 1985, 7:595-606.
26. Jeffery G.M. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull. WHO 1966, 35:873-882.
27. Kauth C.W., Woehlbier U., Kern M., Mekonnen Z., Lutz R., Mücke N., Langowski J., Bujard H. Interactions between merozoite surface proteins 1, 6, and 7 of the malaria parasite Plasmodium falciparum. Biol. Chem. 2006, 281:31517-31527.
28. Kooij T., Carlton J.M., Bidwell S.L., Hall N., Ramesar J., Janse C.J., Waters A.P. Plasmodium whole-genome synteny map, Indels and synteny breakpoints as foci for species-specific genes. PLoS Pathol. 2005, 1:349-361.
29. Li H., Ruan J., Durbin R. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 2008, 18:1851-1858.
30. Malkin E.M., Diemert D.J., McArthur J.H., Perreault J.R., Miles A.P., Giersing B.K., Mullen G.E., Orbutt A., Awkal M., Zhou H., Want J., Stowers A.W., Long C.A., Mahanty S., Miller L.H., Saul A., Durbin A.P. Phase 1 clinical trial of apical membrane antigen 1, an asexual blood-stage vaccine for Plasmodium falciparum malaria. Infect. Immun. 2005, 73:3677-3685.
31. Martinelli A., Cheesman S., Hunt P., Culleton R., Raza A., Mackinnon M., Carter R. A genetic approach to the de novo identification of targets of strain-specific immunity in malaria parasites. Proc. Natl. Acad. Sci. USA 2005, 102:814-819.
32. McGregor I.A., Gilles H.M., Walters J.H., Davies A.H. Effects of heavy and repeated malarial infections on Gambian infants and children; effects of erythrocyte parasitization. Br. Med. J. 1956, 2:686-692.
33. Mullen G.E., Ellis R.D., Miura K., Malkin E., Nolan C., Hay M., Fay M.P., Saul A., Zhu D., Rausch K., Moretz S., Zhou H., Long C.A., Miller L.H., Treanor J. Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909, an asexual blood-stage vaccine for Plasmodium falciparum malaria. PLoS ONE 2008, 3:e2940.
34. McGregor I.A. Mechanisms of acquired immunity and epidemiological patterns of antibody responses in malaria in man. Bull. WHO 1974, 50:259-266.
35. Ockenhouse C.F., Angov E., Kester K.E., Diggs C., Soisson L., Cummings J.F., Stewart A.V., Palmer D.R., Mahajan B., Krzych U., Tornieporth N., Delchambre M., Vanhandenhove M., Ofori-Anyinam O., Cohen J., Lyon J.A., Heppner D.G. MSP-1 Working Group. Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine. Vaccine 2006, 24:3009-3017.
36. Pattaradilokrat S., Cheesman S.J., Carter R. Linkage group selection, towards identifying genes controlling strain specific protective immunity in malaria. PLoS ONE 2007, 2:e857.
37. Sharkey A., Langsley G., Patarapotikul J., Mercereau-Puijalon O., McLean A.P., Walliker D. Chromosome size variation in the malaria parasite of rodents, Plasmodium chabaudi. Mol. Biochem. Parasitol. 1988, 28:47-54.
38. Sirima S.B., Nebie I., Ouedraogo A., Tiono A.B., Konate A.T., Gansane A., Derme A.I., Diarra A., Ouedraogo A., Soulama I., Cuzzin-Ouattara N., Cousens S., Leroy O. Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide MSP3-LSP. Malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa. Vaccine 2007, 25:2723-2732.
39. Stoute J.A., Gombe J., Withers M., Siangla J., McKinney D., Onyango M., Cummings J.F., Milman J., Tucker K., Soisson L., Stewart V.A., Lyon J.A., Angov E., Leach A., Cohen J., Kester K.E., Ockenhouse C.F., Holland C.A., Diggs C., Wittes J., Heppner D.G. MSP-1 Malaria Vaccine Working Group. Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya. Vaccine 2007, 25:176-184.
40. Walliker D., Carter R., Sanderson A. Genetic studies on Plasmodium chabaudi, recombination between enzyme markers. Parasitology 1975, 70:19-24.
41. Wijayalath W.A., Cheesman S., Rajakaruna J., Handunnetti S.M., Carter R., Pathirana P.P. Evidence for strain-specific protective immunity against blood-stage parasites of Plasmodium cynomolgi in toque monkey. Parasite Immunol. 2008, 30:630-636.